Optogenetics Pioneers Deisseroth, Hegemann and Nagel Receive 2026 Nobel Prize in Physiology or Medicine

Karl Deisseroth, Peter Hegemann and Georg Nagel [Images, left to right: Christopher P. Michel; Millencolin, CC BY-SA 4.0 via Wikimedia Commons; third image used with permission, no attribution required.]

The 2026 Nobel Prize in Physiology or Medicine recognizes work at the crossroads of biology, genetics and optics and photonics.

The Nobel Assembly at Karolinska Institutet, Sweden, has awarded the prize jointly to Karl Deisseroth of Stanford University, USA; Peter Hegemann of Humboldt University of Berlin, Germany; and Georg Nagel of the University of Würzburg, Germany, “for their discoveries concerning light-gated ion channels and optogenetics.”

Their work laid the foundation for the field of optogenetics, a method that allows researchers to use light to turn the activity of selected nerve cells on or off. The technique has given neuroscientists a powerful way to move beyond observing correlations between brain activity and behavior and directly test the roles of defined cells and neural circuits.

“Optogenetics provides opportunities for mapping the brain in a way that we could once only dream of,” Per Svenningsson, chair of the Nobel Committee for Physiology or Medicine, said in announcing the award.

For the optics and photonics community, the connection is particularly direct. In optogenetics, light is not simply used to image or monitor a biological process: It provides the control signal itself. By delivering light of an appropriate wavelength to cells genetically engineered to express photosensitive proteins, researchers can alter their electrical activity with millisecond-scale precision.

Finding a molecular light switch

The story behind the prize begins with a single-celled green alga called Chlamydomonas reinhardtii. Hegemann had been investigating how the microorganism responds to light, including how it senses illumination and swims toward or away from it. That work focused attention on microbial rhodopsins—proteins that can convert absorbed light into biological activity.

Nagel, Hegemann and colleagues helped establish the molecular mechanism underlying that photosensitivity. In a 2002 article in Science, they reported a protein from C. reinhardtii that they called channelrhodopsin-1. When expressed in frog oocytes, it generated a conductance when illuminated, behaving as a light-gated proton channel.

The following year, in a PNAS paper, the researchers characterized channelrhodopsin-2 (ChR2), showing that it functioned as a directly light-gated, cation-selective membrane channel. Blue light opens the channel, allowing positively charged ions to cross the cell membrane and generate an electrical response.

The mechanism provided something researchers had long wanted: a molecular switch capable of translating light into a rapid electrical response. Crucially, Hegemann and Nagel found that cells into which the protein was introduced could themselves be made sensitive to light, a property that would prove transformative for neuroscience.

From algae to neurons

Light has long been central to biology as a means of observation, from conventional microscopy to fluorescence, confocal, multiphoton and super-resolution imaging. In optogenetics, however, light becomes an actuator.

The mammalian brain presents a longstanding experimental challenge: It contains enormous numbers of interconnected nerve cells and traditional electrical stimulation can activate many cells near an electrode at once, making it difficult to determine which specific cell type or circuit is responsible for an observed behavior.

Deisseroth, Nagel and collaborators saw the potential of channelrhodopsin to provide a precise tool by combining genetic targeting with optical control. In a 2005 paper in Nature Neuroscience, Edward Boyden, Feng Zhang, Ernst Bamberg, Nagel and Deisseroth introduced ChR2 into mammalian neurons and used optical stimulation to control their electrical activity on millisecond timescales. Genetic techniques could determine which cells expressed the light-sensitive protein, while optical techniques determined when those cells were activated.

The approach was subsequently extended to the intact mammalian brain. In 2007, researchers demonstrated light-driven control of neural circuitry in living mice, helping establish optogenetics as a powerful tool for probing neural circuits in vivo. Its significance was profound: researchers could move beyond simply recording neural activity and instead selectively activate or silence defined populations of neurons to test whether a specific circuit actually caused a particular behavior.

Light as an actuator

That distinction also explains why the work has such a strong connection to optics and photonics. Light has long been central to biology as a means of observation, from conventional microscopy to fluorescence, confocal, multiphoton and super-resolution imaging. In optogenetics, however, light becomes an actuator.

When a channelrhodopsin absorbs a photon, the protein changes conformation, its ion channel opens and charged particles cross the cell membrane, altering the cell's electrical state. Optical energy is thus converted directly into a precisely timed biological signal.

The response can be exceptionally fast: The landmark 2005 work demonstrated millisecond-scale optical control of neuronal spikes, a timescale well matched to the electrical signaling of neurons.

The optical engineering surrounding the molecular tools has continued to develop as well. Delivering light to specific cells (often deep inside scattering brain tissue) requires precise spatial, temporal and spectral control. Fiber optics, microscopy, holography and integrated photonics have all become part of the optogenetics toolkit.

The proteins themselves have also been engineered for different spectral responses and kinetic properties, expanding the wavelengths and timescales available for control.

The result is a technology in which molecular photophysics and optical-system design work together: Genetics defines the target, a photosensitive protein provides the light-responsive interface and photonics delivers the command.

Illuminating how the brain works

Since its first demonstrations in neurons, optogenetics has become a widely used neuroscience tool. Researchers have applied it to map neural circuits involved in movement, memory, motivation, sleep, fear and other behaviors, and to investigate circuits relevant to neurological and psychiatric disorders.

Its impact comes partly from the specificity with which experiments can be designed. Genetic targeting can make selected neuronal populations light-sensitive, while precisely timed illumination allows researchers to test whether those cells play a causal role in a biological function or behavior.

The method also illustrates how far a basic-science discovery can travel: Studies of how a microscopic alga detects light ultimately supplied a molecular tool for manipulating neurons in mammals.

Clinical applications remain considerably less established, although researchers are exploring possibilities including restoring some visual function in people with impaired sight.

A crossroads of disciplines

Deisseroth has continued to develop optical and molecular tools for controlling and observing biological systems. Hegemann has advanced the biophysics and engineering of channelrhodopsins, while Nagel has helped define the molecular properties that made these light-sensitive proteins useful for cellular control.

Together, their work highlights the interdisciplinary nature of modern biophotonics, spanning photobiology, molecular engineering, genetics, neuroscience and optical instrumentation.

Its central achievement is elegantly simple: optogenetics transformed light from a tool for observing the nervous system into a means of communicating with it, opening new ways to probe how cells and circuits generate behavior.